Due to the current crisis of COVID-19 pandemic in Thailand, the in-person conference is not allowed. The APBMT 2021 Organizing Committee has to organize the 26th Congress of Asia Pacific Blood and Marrow Transplantation (APBMT 2021) as a Virtual event.

Message from President

Dear friends and colleagues,
I hope this message will find you all well. I believe that we are all working very hard to get us through this difficult time during the last couple of years. Though the pandemic is very challenging, we have witnessed how great human endeavor against this pandemic can be. Many scientific achievements have been accomplished within record breaking time. And I believe that stem cell transplantation and cell therapy will benefit from these progresses as well.

It is an honor for The Thai Society of Hematology to be the host of Asia Pacific Blood and Marrow Transplantation (APBMT) Congress this year. The Congress will be held in Chiang Mai, Thailand on October 15-17, 2021. We will carry on the tradition of APBMT in promoting collaborative works in this region and around the world, together with bringing state of the arts education topics to the audience. The collaboration and experience sharing are at their best if we can meet on site. However, we are planning for this Conference as a hybrid meeting if the situation does not permit or international travelling cannot resume to normalcy.

I would like to cordially invite you to join us in the 26th APBMT Congress. Chiang Mai is a very beautiful and pleasant city. It has been a major tourist destination for several decades due to its charming culture and environment. It would be a great honor for us to welcome you there.

Artit Ungkanont, M.D.
President, APBMT 2021

Meeting Room 1
Time Title
Haploidentical stem cell transplantation

•    Introduction
Jong Wook Lee
     St. Mary's Hospital, The Catholic University of Korea, Korea
     Usanarat Anusrathapan
     Ramathibodi Hospital, Mahidol University, Thailand
•    Optimizing outcome of haploidentcal HSCT for severe aplastic anemia
     Regis Peffault de Latour (France)

Haploidentical stem cell transplantation

•    Haploidentical transplant in genetic diseases
     Suradej  Hongeng (Thailand)

Haploidentical stem cell transplantation


Refreshment | Exhibition
Transplantation and cellular therapy in leukemia

•   Introduction
    He Huang
    Zhejiang University School of Medicine, Hangzhou, China
    Pimjai Niparuck
    Ramathibodi Hospital, Mahidol University, Thailand

Transplantation and cellular therapy in leukemia

•   Timing of transplantation in acute leukemia and MDS 
    Daniel Weisdorf (USA)

Transplantation and cellular therapy in leukemia

•   New paradigm in cell and gene therapy in leukemia
    Gottlieb DJ (Australia)

Transplantation and cellular therapy in leukemia


Luncheon Symposium III: AMGEN

Moderator: Suradej Hongeng (Thailand)

•    Bi-Specific antibody for the treatment of ALL
     Gökbuget Nicola (Germany)
     Katsu Yoshi Koh (Japan)

Special Lecture

Chairperson: Suradej Hongeng (Thailand)

•    How important is the conditioning regimen to the outcome of allogeneic HSCT?
        Andrea Bacigalupo (Italy)

Transplantation in special population

•    Introduction
Navin Khatty
     Tata Memorial Center, India
     Ekapun Karoopongse
     Siriraj Hospital, Mahidol Univ., Thailand
•    Transplantation and pharmacokinetic monitoring
     Japp J. Boelens (USA)

Transplantation in special population

•    Allogeneic HCT for elderly with hematological malignancies
     Naoyuki Uchida (Japan)

Transplantation in special population

•    Multi-organ transplantation (Amyloidosis – Kidney and BMT)
     Vivek Roy (USA)

Transplantation in special population


Meeting Room 2
Time Title
Cellular therapy in lymphoma/myeloma

•    Chair
William Hwang
     National Cancer Centre Singapore, Singapore
     Kitsada Wudhikarn
     Department of Medicine, Chulalongkorn University, Thailand

Cellular therapy in lymphoma/myeloma

•    CAR T cell therapy in lymphoma: Learning from real world data
     Miguel-Angel Perales (USA)

Cellular therapy in lymphoma/myeloma

•    Management of relapsed lymphoma before and after CAR T cell infusion 
     Francesca Lim (Singapore)

Cellular therapy in lymphoma/myeloma

•    Cell therapy for B-cell lymphoma: CAR-T and others
     Su-Peng Yeh (Taiwan)

Cellular therapy in lymphoma/myeloma

Q and A

Refreshment | Exhibition
Highlight of pharmacy aspects in transplantation and cellular therapy

•    Chair
Adisak Tantiworawit
     Faculty of Medicine, Chiang Mai University

Highlight of pharmacy aspects in transplantation and cellular therapy

•    Common drug interaction and management in BMT patients
     Trai Tharnpanich (Thailand)

Highlight of pharmacy aspects in transplantation and cellular therapy

•    Managing patients receiving CAR-T cell therapy from pharmacist perspective: Our Singapore experience
     Ho Ying Shi (Singapore)

Highlight of pharmacy aspects in transplantation and cellular therapy

•    Pharmacist role in HSCT unit
     Bo Yu (China)

Highlight of pharmacy aspects in transplantation and cellular therapy

Q and A

APBMT General Assembly
Practical points of nursing care in stem cell transplantation

•    Chair
     Godfrey Chi-Fung Chan        
     Oytip Nathalang
      Faculty of Allie Health Sciences, Thammasat University, Thailand

Practical points of nursing care in stem cell transplantation

•    Transplantation complications; mucositis, VOD, hemorrhagic cystitis: nursing perspective
     Lim Yan Yin (Singapore)

Practical points of nursing care in stem cell transplantation

•    The nursing role of selected T cells depleted haloid HSCT
     Scarlett Ho (Hong Kong)



APBMT Executive Board

Chair Shinichiro Okamoto (Japan)
Vice-Chair Alok Srivastava (India)
Members David D. Ma (Australia)
He Huang (China)
Amir Ali Hamidieh (Iran)
Jong Wook Lee (Korea)
William YK Hwang (Singapore)

APBMT 2021 Organizing Committee

Chair Shinichiro Okamoto (Japan)
Vice-Chair Alok Srivastava (India)
Advisors Saengsuree Jootar
Surapol Issaragrisil
Tanin Intragumtornchai
Ponlapat Rojnuckarin
President Artit Ungkanont
Chair of Scientific Program Suradej Hongeng
Co-Chair of Scientific Program Udomsak Bunworasate
Secretary-General 1 Adisak Tantiworawit
Secretary-General 2 Usanarat Anurathapan
Members Ekapun Karoopongse
Kanhatai Chiengthong
Kannadit Prayongratana
Kitsada Wudhikarn
Kleebsabai Sanpakit
Oytip Na Thalang
Pimjai Niparuck
Piya Rujkityanont
Vandee Ningsanond


Usanarat Anurathapan

Ramathibodi Hospital, Mahidol University Bangkok, Thailand

Division of Hematology and Oncology Department of Pediatrics

Japp J. Boelens

Transplantation and Cellular Therapy Center Department of Pediatrics Memorial Sloan Kettering Cancer Center New York, NY, USA

Nelson Chao

Division of Hematologic Malignancies and Cellular Therapy Department of Medicine, Duke University School of Medicine Durham, North Carolina, USA

Godfrey Chi-Fung Chan

Department of Paediatrics & Adolescent Medicine, Queen Mary Hospital & HKU-Shenzhen Hospital, The University of Hong Kong, Hong Kong

Sharat Damodar

The Bone Marrow Transplant Unit Narayana Health City Mazumdar Shaw Medical Center Bangalore, Karnataka, India

Stella Davies

Division of Bone Marrow Transplantation and Immune Defficiency Cincinnati Children’s Hospital Medical Center Cincinnati, Ohio, USA

Juan Du

The Second Military Medical University Shanghai, P.R. China

Department of Hematology The Myeloma & Lymphoma Center Shanghai Changzheng Hospital

David Gottlieb

Westmead Clinical School The Westmead Institute for Medical Research – BMT University of Sydney, Australia

Hildegard Greinix

Waehringer Guertel, Vienna, Austria

Department of Medicine I Bone Marrow Transplantation Unit University of Vienna

Amir Ali Hamidieh

Tehran University of Medical Sciences Tehran, Iran

Pediatric Stem Cell Transplant Department Children’s Medical Center

Rupert Handgretinger

Department of Hematology/Oncology Children’s University Hospital Tubingen Germany

Suradej Hongeng

Ramathibodi Hospital, Mahidol University Bangkok, Thailand

Division of Hematology and Oncology Department of Pediatrics

William Hwang

National Cancer Centre Singapore

Yoshihiro Inamoto

Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo, Japan

Natee Jearawiriyapaisarn

Thalassemia Research Center Institute of Molecular Biosciences Mahidol University, Nakhon Pathom 73170, Thailand

Nutcharee Jungvanichar

Chief Nursing Officer Bumrungrad International Hospital Bangkok, Thailand

Hiroshi Kawamoto

Laboratory of Immunology Institute for Frontier Life and Medical Sciences (IFLMS) Kyoto University, Japan

Bor Sheng Ko

Department of Internal Medicine National Taiwan University Hospital (China, Taiwan)

Nicolaus Kröger

Department of Stem Cell Transplantation University Hospital Hamburg – Eppendorf Hamburg, Germany

Philippe Leboulch

Department of Medicine Brigham and Women’s Hospital 75 Francis St., Boston, MA 02115, USA

Pamela Lee

Department of Paediatrics & Adolescent Medicine Queen Mary Hospital, The University of Hong Kong Hong Kong

John E. Levine

The Mount Sinai School of Medicine Director of BMT Clinical Research New York, USA

Francesca Lorraine Lim

Department of Haematology Singapore General Hospital Singapore

David Ma

St.Vincent’s Clinical School University of New South Wales, Australia

Lt.Gen.Velu Nair

Internal Medicine, Clinical Hematology & Bone Marrow Transplant Armed Forces Medical Service, India

Shinichro Okamoto

Division of Hematology Department of Medicine Keio University of Medicine Tokyo, Japan

Vivek Roy

Division of Hematology/Oncology Department of Internal Medicine Mayo Clinic Jacksonville Jacksonville, Florida, 32224 USA

Matthew Porteus

Institute of Stem Cell Biology & Regenerative Medicine Department of Pediatrics, Division of Hematology/Oncology and Human Gene Therapy Stanford School of Medicine USA

Ho Ying Shi

Block 7 Level 2 Haematology Pharmacy Singapore General Hospital Singapore

John A. Snowden

Director of BMT, Sheffield Teaching Hospitals NHS Foundation Trust & University of Sheffield, Sheffield, UK

Shui Yen Soh

Paediatric Haematology/Oncology Service KK Women's and Children's Hospital (KKH), Singapore.

Alok Srivastava

Department of Haematology Christian Medical College, Vellore, India

Takanori Teshima

Department of Hematology Director, Hematology and BMT program Hokkaido University, Japan

Dr.Trai Tharnpanich

Department of Pharmacy Practice, Chulalongkorn University, 254, Phayathai Road, Pathumwan, Bangkok 10330 Thailand

Naoyuki Uchida

Department of Hematology Toranomon Hospital Tokyo 105‐0001, Japan.

Daniel Weisdorf

Division of Hematology, Oncology and Transplantation University of Minnesota, Minneapolis, USA

Kitsada Wudhikarn

Division of Hematology Department of Medicine King Chulalongkorn Memorial Hospital Chulalongkorn University, Bangkok, Thailand

Lim Yan Yin

Nurse Manager the Children’s Cancer Centre KK Women’s and Children’s Hospital Singapore

Bo Yu

Deputy Chief Pharmacist Department of Pharmacy, Shanghai Tongren Hospital 1111 Xian-Xia Road, Shanghai 200032; P.R. China

Robert Zeiser

Hematology and Oncology University Medical Center Freiburg Freiburg, Germany